N
Nemysis develops a nano-particulate iron supplement, Iron Hydroxide Adipate Tartrate (IHAT), that mimics natural iron absorption to reduce gastrointestinal side effects commonly associated with traditional iron supplements. The company also creates an endoprotease, E40, which breaks down gluten peptides to alleviate discomfort for patients with Coeliac Disease and Non-Celiac Gluten Sensitivity.
Updated 20 months ago
Funding
$6.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Nemysis develops a nano-particulate iron supplement, Iron Hydroxide Adipate Tartrate (IHAT), that mimics natural iron absorption to reduce gastrointestinal side effects commonly associated with traditional iron supplements. The company also creates an endoprotease, E40, which breaks down gluten peptides to alleviate discomfort for patients with Coeliac Disease and Non-Celiac Gluten Sensitivity.